×
验证码:
换一张
忘记密码?
记住我
×
登录
中文版
|
English
中国科学院金属研究所机构知识库
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
资助项目
文献类型
出处
收录类别
出版者
发表日期
存缴日期
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
作者
文献类型
期刊论文 [11]
发表日期
2017 [4]
2016 [3]
2015 [1]
2013 [2]
2008 [1]
语种
英语 [11]
出处
ACTA PHARM... [4]
CHEMICAL R... [3]
CHINESE CH... [2]
NEURAL REG... [2]
资助项目
[National ... [7]
["Interdis... [2]
[Foundatio... [2]
[National ... [2]
[Program f... [2]
[Program o... [2]
更多...
收录类别
CSCD [10]
SCI [1]
资助机构
China Post... [1]
National N... [1]
×
知识图谱
IMR OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
WOS被引频次升序
WOS被引频次降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
期刊影响因子升序
期刊影响因子降序
作者升序
作者降序
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
;
Chen Guzhou
;
Zhao Qingchun
;
Hu Chun
收藏
  |  
浏览/下载:147/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
;
Chen Guzhou
;
Zhao Qingchun
;
Hu Chun
收藏
  |  
浏览/下载:141/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells
期刊论文
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:
Qin MingZe
;
Wang Lei
;
Yan Shuang
;
Ma JunJie
;
Tian Ye
;
Zhao YanFang
;
Gong Ping
收藏
  |  
浏览/下载:153/0
  |  
提交时间:2021/02/02
TYROSINE KINASE INHIBITOR
LUNG-CANCER
RECEPTOR
T790M
MUTANT
MUTATION
Aminopyrimidines
EGFR T790M/L858R
Selectivity
Anti-resistance
Antiproliferative activity
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells
期刊论文
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:
Qin MingZe
;
Wang Lei
;
Yan Shuang
;
Ma JunJie
;
Tian Ye
;
Zhao YanFang
;
Gong Ping
收藏
  |  
浏览/下载:135/0
  |  
提交时间:2021/02/02
TYROSINE KINASE INHIBITOR
LUNG-CANCER
RECEPTOR
T790M
MUTANT
MUTATION
Aminopyrimidines
EGFR T790M/L858R
Selectivity
Anti-resistance
Antiproliferative activity
Biodegradable magnesium wire promotes regeneration of compressed sciatic nerves
期刊论文
NEURAL REGENERATION RESEARCH, 2016, 卷号: 11, 期号: 12, 页码: 2012-2017
作者:
Li, Bo-han
;
Yang, Ke
;
Wang, Xiao
收藏
  |  
浏览/下载:128/0
  |  
提交时间:2021/02/02
nerve regeneration
peripheral nerve regeneration
biodegradable
magnesium wire
sciatic nerve
rats
nerve growth factor
P75 neurotrophin receptor
tyrosine receptor kinase A
neural regeneration
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:
Liu Tongchao
;
Peng Xia
;
Ma Yuchi
;
Ji Yinchun
;
Chen Danqi
;
Zheng Mingyue
;
Zhao Dongmei
;
Cheng Maosheng
;
Geng Meiyu
;
Shen Jingkang
;
Ai Jing
;
Xiong Bing
收藏
  |  
浏览/下载:153/0
  |  
提交时间:2021/02/02
RECEPTOR TYROSINE KINASE
INVASIVE GROWTH
SCATTER FACTOR
CANCER
DOCKING
c-Met inhibitors
hepatocyte growth factor receptor
imidazo1,2-apyridine
anticancer agents
drug discovery
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:
Liu Tongchao
;
Peng Xia
;
Ma Yuchi
;
Ji Yinchun
;
Chen Danqi
;
Zheng Mingyue
;
Zhao Dongmei
;
Cheng Maosheng
;
Geng Meiyu
;
Shen Jingkang
;
Ai Jing
;
Xiong Bing
收藏
  |  
浏览/下载:129/0
  |  
提交时间:2021/02/02
RECEPTOR TYROSINE KINASE
INVASIVE GROWTH
SCATTER FACTOR
CANCER
DOCKING
c-Met inhibitors
hepatocyte growth factor receptor
imidazo1,2-apyridine
anticancer agents
drug discovery
Discovery of Novel Tricyclic 5H-Pyridazino4,5-bindoles as Potent Antitumor Agents: Design, Synthesis and Biological Evaluation
期刊论文
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2015, 卷号: 31, 期号: 3, 页码: 372-380
作者:
Zhai Xin
;
Wang Limei
;
Shi Jiyue
;
Gong Ping
收藏
  |  
浏览/下载:123/0
  |  
提交时间:2021/02/02
TYROSINE KINASE INHIBITORS
GROWTH-FACTOR RECEPTOR
ANALOGS
DERIVATIVES
BINDING
HARMINE
1-Anilino-5H-pyridazino4,5-bindole
EGFR inhibitor
Cytotoxicity
Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations
期刊论文
ACTA PHARMACOLOGICA SINICA, 2013, 卷号: 34, 期号: 11, 页码: 1475-1483
作者:
Yu Zhe
;
Ma Yuchi
;
Ai Jing
;
Chen Danqi
;
Zhao Dongmei
;
Wang Xin
;
Chen Yuelei
;
Geng Meiyu
;
Xiong Bing
;
Cheng Maosheng
;
Shen Jingkang
收藏
  |  
浏览/下载:145/0
  |  
提交时间:2021/02/02
SULFUR-PI INTERACTIONS
PERTURBATION-THEORY
SUBSTITUENTS
SANDWICH
BENZENE
PATHWAY
receptor tyrosine kinase
type I c-Met inhibitor
cancer
quantum chemistry
protein-ligand interaction
symmetry-adapted perturbation theory (SAPT)
Energetic factors determining the binding of type I inhibitors to c-Met kinase: experimental studies and quantum mechanical calculations
期刊论文
ACTA PHARMACOLOGICA SINICA, 2013, 卷号: 34, 期号: 11, 页码: 1475-1483
作者:
Yu Zhe
;
Ma Yuchi
;
Ai Jing
;
Chen Danqi
;
Zhao Dongmei
;
Wang Xin
;
Chen Yuelei
;
Geng Meiyu
;
Xiong Bing
;
Cheng Maosheng
;
Shen Jingkang
收藏
  |  
浏览/下载:107/0
  |  
提交时间:2021/02/02
SULFUR-PI INTERACTIONS
PERTURBATION-THEORY
SUBSTITUENTS
SANDWICH
BENZENE
PATHWAY
receptor tyrosine kinase
type I c-Met inhibitor
cancer
quantum chemistry
protein-ligand interaction
symmetry-adapted perturbation theory (SAPT)